Category Industries
Press Release
CCL Industries Announces 2024 Fourth Quarter and Record Annual Results
Fourth Quarter Highlights Per Class B share(3): $1.02 adjusted basic earnings up 5.2%; $1.01 basic earnings up 359.1%; $0.54 goodwill impairment loss in 2023 basic earnings; currency translation negative $0.01 per share Sales increased 9.0% on 6.8% organic growth, 1.4% acquisition growth and 0.8% positive currency translation CCL, Checkpoint and Innovia posted organic sales growth of 5.4%, 13.3%, and 20.2%, respectively, partly offset by an organic decline for Avery of 2.0% Operating income(1) improved 5.1%, with a 14.8% operating margin(1) down 50 bps 2024 Highlights Per Class B share(3): $4.32 adjusted basic earnings up 14.9%; $4.73 basic earnings up 58.2%; $0.44 revaluation gain included in 2024 basic earnings and $0.54 goodwill impairment loss in 2023 basic earnings; currency translation negative $0.02 per share Sales increased 9.0% on 6.1% organic growth, 2.3% acquisition growth and 0.6% positive currency translation Operating income(1) improved 13.0%, with a 15.8% operating margin(1) up 60 bps Read More
Press Release
Compassion Center Honors Pioneering Cannabinologist Dr. David Bearman for Decades of Transformative Work in Integrative Health and Medical Cannabis, Announces Leadership Promotion Around a National Expansion
Compassion Center proudly honors Dr. David Bearman for his pioneering work in medical cannabis, integrative healthcare, and patient advocacy. As Dr. Bearman retires, his legacy lives on through initiatives like CBCCERN, TeachOneServe10.org, and IntegrativeECS, reshaping care for millions. Amie Lindsay steps into a new leadership role, driving national expansion while preserving Compassion Center's mission: providing compassionate, evidence-based care and advancing integrative medicine across the U.S. Read More
Press Release
Compassion Center Calls for Media Accountability Amid Ongoing DEA Cannabis Rescheduling Hearings
Compassion Center urges media outlets to report accurately on the DEA's active cannabis rescheduling hearings, emphasizing the importance of factual coverage during this pivotal regulatory process. Suggesting that the hearing is cancelled is a lie. Misinformation like this risks undermining patient access, public trust, and informed policymaking as the DEA evaluates moving cannabis to a Schedule III substance under the Controlled Substances Act (CSA). Compassion Center remains committed to providing expert insights and advocating for patie Read More
Press Release
Auto Loan Fraud on the Rise: Petroff Amshen LLP Helps Consumers Reclaim Their Financial Stability
Identity theft and credit reporting mistakes tied to auto loans are leaving consumers with financial headaches. Petroff Amshen LLP is stepping in to offer legal solutions that help people regain control of their credit reports and financial well-being. Read More
